New approach aims to tame dangerous potassium levels in kidney patients
NCT ID NCT06884267
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This study looks at whether a standardized treatment plan can help chronic kidney disease patients with high potassium levels (hyperkalemia) better control their condition and optimize their medications. About 1,000 adults with kidney disease and high potassium will follow a guideline-based management program for 48 weeks. The goal is to see if more patients can achieve normal potassium levels while staying on important heart and kidney protective drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100029, China
-
Research Site
Benxi, 117000, China
-
Research Site
Changchun, 130041, China
-
Research Site
Changsha, 410008, China
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 410300, China
-
Research Site
Chengdu, 610031, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chengdu, 610078, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Dalian, 116023, China
-
Research Site
Fuyang, 236600, China
-
Research Site
Fuzhou, 350005, China
-
Research Site
Fuzhou, 350031, China
-
Research Site
Gejiu, 661099, China
-
Research Site
Guangzhou, 510280, China
-
Research Site
Guangzhou, 510530, China
-
Research Site
Guiyang, 510630, China
-
Research Site
Haikou, 570311, China
-
Research Site
Hangzhou, 310006, China
-
Research Site
Hefei, 230001, China
-
Research Site
Hohhot, 10050, China
-
Research Site
Jinan, 250012, China
-
Research Site
Jinan, 250021, China
-
Research Site
Kunming, 650021, China
-
Research Site
Kunming, 650101, China
-
Research Site
Lanzhou, 730030, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanning, 530021, China
-
Research Site
Nantong, 226001, China
-
Research Site
Ningbo, 315010, China
-
Research Site
Pingdingshan, 467000, China
-
Research Site
Qiqihar, 161000, China
-
Research Site
Shanghai, 200025, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shanghai, 200233, China
-
Research Site
Shenyang, 110001, China
-
Research Site
Shijiazhuang, 50051, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Tianjin, 300192, China
-
Research Site
Ürümqi, 830054, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhu, 241000, China
-
Research Site
Wuxi, 214062, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Xining, 810001, China
-
Research Site
Xinxiang, 453100, China
-
Research Site
Yinchuan, 750004, China
-
Research Site
Zhengzhou, 450003, China
Conditions
Explore the condition pages connected to this study.